By means of simple letter to the General Director of the Research and Technological Transfer General Office (OGITT) of the National Health Institute_
- Notification for Early Termination of Clinical Trial.
- Notification for Transfer or Delegation of responsibilities in authorized clinical trials (within the framework of Article 41° of the Clinical Trials Regulation in Peru).
- Research Product Safety Reports (except Reas-Net).
- Reference for Investigator’s Brochure updates.
- Other notifications